Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Performance of Stenfilcon A Versus Filcon II 3

NCT01808209 is registered in ClinicalTrials.gov with CooperVision, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01808209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Performance of Stenfilcon A Versus Filcon II 3
Lead sponsor
CooperVision, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
May 31, 2013
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.